Job
Description
Job Overview Responsible for managing and maintaining Quality Management System (QMS) activities within the Supply Chain Management (SCM) department, including Change Control, Deviation, and CAPA management. Ensures daily operations and documentation are in compliance with cGMP and regulatory standards. Supports audit readiness and continuous improvement initiatives within SCM. Key Stakeholders: Internal QA/QC/Production Key Stakeholders: External Vendor and Auditors Reporting Structure SCM Head Experience Minimum 2 –4 years of relevant experience in the Pharmaceutical Industry , with hands-on exposure to SCM and QMS functions. Competencies Analytical thinking and problem-solving ability Strong communication and interpersonal skills Ability to collaborate cross-functionally Proactive and self-motivated approach to compliance and improvement initiatives Roles and Responsibilities: • Manage and maintain Quality Management System (QMS) activities within the SCM department, including Change Control, Deviation, and CAPA. • Ensure all SCM operations and documentation comply with cGMP, GDP, and relevant regulatory guidelines (USFDA, WHO, MHRA, etc.). • Act as a key interface between SCM and QA/QC/Production teams to ensure seamless quality compliance. • Support audit readiness and manage audit-related documentation and follow-ups. • Drive continuous improvement initiatives within SCM through effective implementation of QMS tools and RCA methods (Why-Why, FMEA, 6M, etc.). • Coordinate with vendors and external auditors to ensure compliance with quality and supply chain standards. • Utilize ERP systems (SAP/Oracle/other SCM tools) to manage supply chain and QMS documentation. • Contribute to vendor qualification processes and material management from a quality perspective. • Foster cross-functional collaboration to resolve quality issues and enhance SCM performance. • Report to the SCM Head, providing regular updates on QMS activities, audit outcomes, and improvement actions. In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth. Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices. Equal employment opportunity Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics. We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice. Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited’s investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovators and generic companies worldwide.
